During the past decade, Mercy General Health Partners conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 39 clinical trials were completed, i.e. on average, 1950% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mercy General Health Partners" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 26 trials, followed by "SWOG Cancer Research Network" with 23 trials sponsored, "NSABP Foundation Inc" with 3 trials sponsored, "Columbia University" with 1 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy General Health Partners" #1 collaborator was "National Cancer Institute (NCI)" with 55 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "SWOG Cancer Research Network" with 3 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator and "Eastern Cooperative Oncology Group" with 2 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Mercy General Health Partners" are "Breast Cancer" (18 trials), "Leukemia" (6 trials), "Lung Cancer" (6 trials), "Lymphoma" (6 trials) and "Prostate Cancer" (5 trials). Many other conditions were trialed in "Mercy General Health Partners" in a lesser frequency.

Most popular intervention types in "Mercy General Health Partners" are "Drug" (41 trials), "Other" (21 trials), "Biological" (14 trials), "Procedure" (7 trials) and "Radiation" (6 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (13 trials), "bevacizumab" (7 trials), "radiation therapy" (5 trials), "biologic sample preservation procedure" (4 trials) and "carboplatin" (4 trials). Other intervention names were less common.

The vast majority of trials in "Mercy General Health Partners" are 42 trials for "All" genders, 14 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Mercy General Health Partners". undefined are not yet recruiting, 1 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 48 completed trials in Mercy General Health Partners, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Mercy General Health Partners, 2 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".